Clinical trials need participants, are the rules about compensation helping or hurting?

The HHS Office of Inspector General is seeking public input on how fraud-and-abuse laws affect payments to clinical-trial participants. The effort could help determine whether existing rules strike the right balance between protecting patients and supporting medical research. Joining me now is Spencer Turnbull, Chief of the Industry Guidance Branch at HHS-OIG.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.